1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
about
Breast cancer chemoprevention: beyond tamoxifenVitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches (review)Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cellsVitamin D suppresses leptin stimulation of cancer growth through microRNA.Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studyTissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapyVitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysisSeasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude.Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cellsFluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsBreast tumor developed in a pregnant rat after treatment with the teratogen CycloheximideInhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.Molecular and cellular determinants of estrogen receptor alpha expression.Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancyEB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancerCalcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approachThe anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells.The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topicInhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.Dietary vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/- miceThe potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer preventionMART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells.Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.Derailed estrogen signaling and breast cancer: an authentic couple.Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer riskVitamin d: are we ready to supplement for breast cancer prevention and treatment?Dynamic regulation of estrogen receptor-alpha gene expression in the brain: a role for promoter methylation?Meta-analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms.Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells.25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ cultureGemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.Bone mass pharmacogenetics and ethnic health implications.Bone Morphogenetic Protein-2 Desensitizes MC3T3-E1 Osteoblastic Cells to Estrogen Through Transcriptional Downregulation of Estrogen Receptor 1.
P2860
Q24793429-059F0204-C3AA-4E9A-AC96-999B8827372FQ26992050-D7F26A0E-917F-4D49-A83D-3D67D1CC78B8Q28359567-EEF05407-D6AD-4771-8D66-74231C411C21Q30367127-93A9CCD7-9F3F-4671-9C09-664DC2DB1DD3Q31001849-5460248E-46E0-46EC-AE5E-1D7F901429C4Q33577548-1DB51950-FC4E-4805-A8D8-2874BE12398CQ33682919-A2435F57-48AF-43D2-A64B-44B62E983498Q33686275-85D976F1-9144-48C4-8D00-3742C0A7C118Q33690078-12AEA7E2-9399-4341-A33A-B8F59B0A0C71Q33808945-D243A394-F7F2-4DA2-AA66-98FADD80B479Q33839150-C2EE0895-F18C-4D1B-B99B-4821CAC254ECQ33953912-467DFAD3-C3B2-41DE-B160-E6EEFA120851Q33976185-F6488937-734B-4C21-9FA9-BC382E0042F8Q34181207-306B2033-C991-4161-A812-9C5D6E1AC403Q35044178-506A9035-6ADE-482B-BCB4-462308289D74Q35090243-28011BDD-97C4-4D04-847C-DBD77B413CACQ35098796-3122C535-F0DD-43BE-B592-AA54513E5E9BQ35134342-CD6B975A-15EA-4775-9B89-29085EFC88FBQ35188826-A038D7F8-9110-4D66-B128-836F44CA634AQ35243693-E568E71E-DA94-41B8-B808-C22AA1CBBC34Q35301775-BD6D70B2-AD5B-4E8C-83F6-0D68C7CBC854Q35441965-EA0F33D3-712D-4DD3-9DDF-0AE08412649AQ35591298-9AAF9C10-99E7-44B5-A5E3-F8A323A47EA3Q35995911-DAB12495-617E-4DF5-88A5-A4DA27E0E488Q36062947-DA3230E6-F139-44D6-B6AA-BF9D15906A01Q36195219-B6F4A7CA-9822-4A1C-AFCC-E64F0CF44137Q36346904-4912D0CC-A3C1-44ED-B82D-883E77AFCD12Q36488819-CC723CFA-83EF-483B-B9B7-D00DDA479556Q36561789-4F11AAC7-48DD-4C40-A06B-C3EADD6B7C8EQ36589361-993337E4-CA63-49D0-996D-EC1278956A03Q36678698-726088DC-B50E-48C7-A94F-2BA359D12DE8Q36692336-4F3BF4CE-CE80-446D-9316-D5549B3B1065Q36762940-2F2B2A62-E121-4527-8774-BB668C5CA4B8Q36947851-ED0A58CC-E29B-4ABD-A7C6-641DF75B71D8Q36957490-37914DD8-B41B-4457-B06B-E28E19BD5EC3Q37075299-FA390360-C37F-41E6-B07C-7C948A9BCBC2Q37226472-8652DA7E-4675-4FD9-BD2B-F7B21C575AABQ37366225-318C6313-03D1-4A5B-9BB8-8B240907A33EQ37430515-0BCCFFBF-2B27-4355-BA7F-F22813840530Q37542700-ABD8A4DB-C329-4A47-A05D-76DF12088829
P2860
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
1alpha,25-Dihydroxyvitamin D3 ...... F-7 human breast cancer cells.
@en
type
label
1alpha,25-Dihydroxyvitamin D3 ...... F-7 human breast cancer cells.
@en
prefLabel
1alpha,25-Dihydroxyvitamin D3 ...... F-7 human breast cancer cells.
@en
P2093
P1476
1alpha,25-Dihydroxyvitamin D3 ...... F-7 human breast cancer cells.
@en
P2093
P304
P407
P577
2000-08-01T00:00:00Z